Search

Your search keyword '"ERα"' showing total 1,628 results

Search Constraints

Start Over You searched for: Descriptor "ERα" Remove constraint Descriptor: "ERα" Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
1,628 results on '"ERα"'

Search Results

1. Antioxidant and Antitumor Potential of Some Benzoxazines Against MCF‐7 Cell Lines Using InVitro and InSilico Approaches.

2. USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα.

3. 黄芪总黄酮通过 ERα/STAT3 信号通路调节子宫 内膜异位症中子宫内膜细胞增殖和迁移.

4. Exploring the Nexus of Steroidal Hormone Receptor, Uterine VEGF Expression and NADPH‐d Interaction in Buffalo Uterus During Oestrous Cycle With Seasonal Variation.

5. Estrogen receptors alpha and beta expression in different canine cancer types with an emphasis on hematopoietic malignancies.

6. USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα

7. Transcription repression of estrogen receptor alpha by ghrelin/Gq/11/YAP signaling in granulosa cells promotes polycystic ovary syndrome.

8. Role of ERα and Aromatase in Juvenile Gigantomastia.

9. LINC00173 silence and estrone supply suppress ER+ breast cancer by estrogen receptor α degradation and LITAF activation.

10. Selective impact of ALK and MELK inhibition on ERα stability and cell proliferation in cell lines representing distinct molecular phenotypes of breast cancer

11. Mitigation of letrozole induced polycystic ovarian syndrome associated inflammatory response and endocrinal dysfunction by Vitex negundo seeds

12. UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast cancer by deubiquitinating and stabilizing KLF5

13. High estrogen during ovarian stimulation induced loss of maternal imprinted methylation that is essential for placental development via overexpression of TET2 in mouse oocytes

14. The Role of Estrogen and Estrogen Receptors in Head and Neck Tumors.

15. Mitigation of letrozole induced polycystic ovarian syndrome associated inflammatory response and endocrinal dysfunction by Vitex negundo seeds.

16. UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast cancer by deubiquitinating and stabilizing KLF5.

17. Metastasis‐associated protein 1 participates in regulating luminal acidification of the epididymis via repressing estrogen receptor alpha transcription.

18. Potential Active Compounds of Propolis as Breast Anticancer Candidates: In Silico Study.

19. Modulation of Estrogen Receptor Alpha (ERα) and Tumor Suppressor Gene BRCA1 in Breast Cancer Cells by Bazedoxifene Acetate (BZA).

20. Notoginsenoside R1 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via ERα/GSK‐3β/β‐catenin signalling pathway.

21. AutoDock and molecular dynamics-based therapeutic potential prediction of flavonoids for primary Sjögren's syndrome

22. Investigating the therapeutic mechanism of Jiedu-Quyu-Ziyin Fang on systemic lupus erythematosus through the ERα-miRNA-TLR7 immune axis

23. An estrogen-regulated long non-coding RNA NCALD promotes luminal breast cancer proliferation by activating GRHL2

24. Screening 2‒mercaptoimidazole derivatives for breast cancer treatment

25. An estrogen-regulated long non-coding RNA NCALD promotes luminal breast cancer proliferation by activating GRHL2.

26. Estrogen Receptor β in the Lateral Septum Mediates Estrogen Regulation of Social Anxiety-like Behavior in Male Mice.

27. Ovaries of estrogen receptor 1-deficient mice show iron overload and signs of aging

28. ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance

29. CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer

31. The G Protein-Coupled Estrogen Receptor (GPER): A Critical Therapeutic Target for Cancer.

32. 2-Benzoxazolinone as Breast Cancer Cells Inhibitor via Estrogen Receptor.

33. ERα prevents tumorigenesis of both liver and breast cancer cells through CCN5.

34. Peering into the Brain's Estrogen Receptors: PET Tracers for Visualization of Nuclear and Extranuclear Estrogen Receptors in Brain Disorders.

35. Resistance to hormone therapy in breast cancer cells promotes autophagy and EGFR signaling pathway.

36. Withania somnifera inhibits photorefractoriness which triggers neuronal apoptosis in both pre-optic and paraventricular hypothalamic area of Coturnix coturnix japonica: involvement of oxidative stress induced p53 dependent Caspase-3 mediated low immunoreactivity of estrogen receptor alpha

37. The effect of hesperetin on estrogen receptor gene expression and its relationship with the downstream pathways of estrogen receptor alpha.

38. Regulation of ERα-dependent breast cancer metastasis by a miR-29a signaling

39. CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer.

40. Estrogen receptor subtype mediated anti-inflammation and vasorelaxation via genomic and nongenomic actions in septic mice.

41. CircPVT1 promotes ER‐positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS.

42. Correlation between oestrogen receptor (ERα) and Ki-67 receptor expression in canine genital neoplasms by immunohistochemistry

43. The ERα-NRF2 signalling axis promotes bicalutamide resistance in prostate cancer

44. Hormones and Cerebellar Development

45. Tumour suppressor TET2 safeguards enhancers from aberrant DNA methylation and epigenetic reprogramming in ERα-positive breast cancer cells

46. Regulation of ERα-dependent breast cancer metastasis by a miR-29a signaling.

47. ERK1/2‐RSK regulation of oestrogen homeostasis.

48. Epigenetics in Canine Mammary Tumors: Upregulation of miR-18a and miR-18b Oncogenes Is Associated with Decreased ERS1 Target mRNA Expression and ERα Immunoexpression in Highly Proliferating Carcinomas.

49. Cyclopia extracts act as selective estrogen receptor subtype downregulators in estrogen receptor positive breast cancer cell lines: Comparison to standard of care breast cancer endocrine therapies and a selective estrogen receptor agonist and antagonist.

50. Molecular regulation of prostate cancer by Galectin-3 and estrogen receptor.

Catalog

Books, media, physical & digital resources